BioSpace News Archive

Business

Vector Pharma FZCO signs Exclusive License and Distribution Rights to IXEMPRA in the Middle East

Vector Pharma FZCO announced today the signing of an exclusive distribution agreement with R-PHARM US of Princeton, NJ.

December 22, 2021
·
2 min read
Genetown

Allarity Therapeutics Submits New Drug Application (NDA) to the U.S. FDA for Dovitinib for Third-Line Treatment of Renal Cell Carcinoma (RCC)

Allarity Therapeutics, Inc. today announced the submission of a new drug application (NDA) with the U.S. Food and Drug Administration (FDA) seeking marketing approval for dovitinib for the third-line treatment of renal cell carcinoma (RCC) patients.

December 22, 2021
·
8 min read
InnovAge Announces Participation at the 40th Annual J.P. Morgan Healthcare Conference

InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail dual-eligible seniors, announced that Maureen Hewitt, Chief Executive Officer, will be presenting virtually at the 40th Annual J.P. Morgan Healthcare Conference.

December 22, 2021
·
1 min read
Drug Development

LogicBio Therapeutics Provides Business Updates

LogicBio Therapeutics, Inc. (Nasdaq: LOGC), a clinical-stage genetic medicine company, today provided updates around its SUNRISE Phase 1/2 clinical trial and development pipeline, and announced the appointment of Susan R. Kahn to its Board of Directors.

December 22, 2021
·
11 min read
FDA

Sight Sciences Receives FDA 510(k) Clearance of the TearCare® System for Treatment of Meibomian Gland Dysfunction (MGD), the Leading Cause of Dry Eye Disease

Sight Sciences, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the TearCare ® System for the treatment of meibomian gland dysfunction (MGD), the leading cause of dry eye disease (DED).

December 22, 2021
·
9 min read
Genetown

Infraredx, a Nipro Company, Announces Enrollment of First Patient in EXPANSE PTCA Study

Infraredx, a Nipro Company, a pioneer in intravascular imaging for mapping coronary artery disease, announced today the enrollment of the first patient in its EXPANSE PTCA study.

December 22, 2021
·
2 min read
Business

Novadoz Pharmaceuticals’ Corporate Group Entity, MSN Pharmaceuticals Inc., Has Received USFDA Clearance for its State-of-the-Art Manufacturing Facility in Piscataway, NJ

Novadoz Pharmaceuticals is excited to announce that their corporate group entity, MSN Pharmaceuticals, has cleared USFDA audit with zero observations for their new, state-of-the-art, 200,000 sq. ft. manufacturing facility in Piscataway, NJ.

December 22, 2021
·
1 min read
Deals

SCYNEXIS Reports the Exercise of Warrants Totalling $21.1 Million

SCYNEXIS, Inc. today reported the exercise of warrants to purchase 3.37 million shares of SCYNEXIS common stock for which SCYNEXIS accepted a reduced exercise price.

December 22, 2021
·
1 min read
Business

Nanalysis Establishes Scientific Advisory Board with Four World Renowned Scientists

Nanalysis Scientific Corp. is pleased to announce that, effective December 21, 2021, it has established a Scientific Advisory Board, with four world renowned scientists as founding members.

December 22, 2021
·
8 min read
Deals

SciSparc’s Ordinary Shares to Commence Trading on Nasdaq Capital Market Today

SciSparc Ltd. today announced that its ordinary shares will start trading today on The Nasdaq Capital Market (“Nasdaq”) under the symbol “SPRC.

December 22, 2021
·
2 min read